Finepoint Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,782,267
| Closed | -$24.9M | – | 28 |
|
|
2024
Q3 | $24.9M | Buy |
1,782,267
+5,539
| +0.3% | +$77.5K | 1.81% | 6 |
|
|
2024
Q2 | $14.6M | Buy |
1,776,728
+127,507
| +8% | +$1.05M | 4.15% | 10 |
|
|
2024
Q1 | $12.7M | Buy |
1,649,221
+213,900
| +15% | +$1.65M | 3.26% | 15 |
|
|
2023
Q4 | $12.9M | Buy |
1,435,321
+539,500
| +60% | +$4.85M | 4.07% | 14 |
|
|
2023
Q3 | $8.01M | Buy |
895,821
+134,100
| +18% | +$1.2M | 3.99% | 13 |
|
|
2023
Q2 | $11.7M | Sell |
761,721
-113,500
| -13% | -$1.74M | 4.05% | 16 |
|
|
2023
Q1 | $19.7M | Sell |
875,221
-151,079
| -15% | -$3.4M | 7.52% | 1 |
|
|
2022
Q4 | $21.6M | Sell |
1,026,300
-2,575
| -0.3% | -$54.2K | 6.98% | 1 |
|
|
2022
Q3 | $25.4M | Buy |
1,028,875
+444,575
| +76% | +$11M | 8.34% | 1 |
|
|
2022
Q2 | $14.2M | Buy |
+584,300
| New | +$14.2M | 4.9% | 11 |
|